StreetAlpha.app
Home › Stocks › ARAY

Accuray Inc (ARAY)

$2.44
▼ −4.31%
LAST CLOSE · NOV 17

Accuray makes radiation therapy systems, planning software and imaging tools for hospitals and cancer centers. It last closed at $2.44 on Nov 17, down 4.31% on the day. ARAY reports earnings on Wed, Feb 3, 2027.

AI Auto Pilots
Is ARAY in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$394.5M
−12.5% vs a year ago
Net income
−$17.4M
−4.4% margin
EPS (diluted)
−$0.15
Free cash flow
−$27.1M
−6.9% margin
Valuation
Market cap
$293.2M
120.2M shares
P/E
–
No P/E while losing money
Price to sales
0.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$42.3M
At Sep 30
Debt
$101.7M
At Sep 30
Shareholder equity
$53.1M
Shares outstanding
120.2M
At Oct 31
Fiscal year endsJune
ExchangeNasdaq
Financials history
FY2022: $429.9M$429.9MFY2022FY2023: $447.6M$447.6MFY2023FY2024: $446.6M$446.6MFY2024FY2025: $458.5M$458.5MFY2025FY2026: $401.9M$401.9MFY2026

From ARAY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
-$2.80
$100.0M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated ARAY in the past 90 days.
Average 12-month target
No price targets on ARAY in the past 90 days.
Latest rating changes
JefferiesDowngrade
May 12Hold$0.35
DateFirmActionRatingPrice target
May 12JefferiesDowngradeHold$0.35
Loading…

Technical Analysis

ARAY · as of the Nov 17 close · updated after every close
Uptrend, overbought

The stock is 53% above its 20 day and 76% above its 50 day average. It is 82% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 67), overbought. The nearest support is the Pivot S1 at $2.32, and the nearest resistance the Pivot at $2.51.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 14.5%/day
Key levels
$4.0552 week high+66.0%
$4.05Swing high (Nov 9)+66.0%
$2.63Pivot R1+7.8%
$2.51Pivot+2.9%
$2.44Last close
$2.32Pivot S1−4.9%
$1.1420 day average−53.3%
$0.6050 day average−75.4%
$0.43100 day average−82.4%
$0.43200 day average−82.4%
$0.31Swing low (Jun 11)−87.3%
$0.1152 week low−95.5%
Indicators
RSI (14)67.24Strong, overbought above 70Neutral
MACD0.70Above its signal lineBullish
Stochastic63.1Middle of its rangeNeutral
ADX (14)37.0Trending up
Williams %R-40.8Oversold below −80, overbought above −20Neutral
CCI (20)67.3Oversold below −100, overbought above 100Neutral
Rate of change+1559.9%Change over 10 sessionsBullish
ATR (14)$0.35Typical daily range, 14.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ARAY

What happened before

See how ARAY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ARAY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ARAY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2007.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ARAY in the last 90 days.

Loading…

See today’s whale options flow across the market →

ARAY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼17 buying vs 79 selling
  • ●Held by funds -0.5 pts
  • ▼Funds holding -20
  • ▼Superinvestors: 0 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding92112−17.9%
In funds' top 1010–
Held by funds59.1%59.6%−0.5 pts
New / increased9 / 826 / 35−72.1%
Reduced / sold out51 / 2828 / 41+14.5%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ARAY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ARAY is in one of them and how their past ARAY trades turned out.

ARAY in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ARAY in an article yet. Here's the latest on the wider market.

About Accuray

Accuray is a radiation therapy company based in Madison, Wisconsin. It makes radiation treatment systems, including the CyberKnife robotic platform and a range of helical systems, along with treatment planning software, imaging technology and related services such as installation, training and customer support. Its customers include hospitals, cancer centers and clinicians, including radiation oncologists and neurosurgeons, who use the equipment to treat tumors and selected neurologic or endocrine disorders where clinically appropriate.

Headquarters
Madison, WI